P3I
ABVX

Progeny 3 Inc’s Abivax ABVX Stock Holding History

Progeny 3 Inc’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Hold
12,240
– – 0.07% 29
2025
Q4 		$1.65M Hold
12,240
– – 0.09% 32
2025
Q3 		$1.04M Buy
+12,240
New +$750K 0.05% 34

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Progeny 3 Inc's ABVX Position: Q1 2026 in Review

Progeny 3 Inc held its Abivax (ABVX) position steady in Q1 2026 at 12,240 shares worth $1.36M. The position accounts for 0.07% of the portfolio, ranked #29.

Progeny 3 Inc first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.65M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Progeny 3 Inc held 12,240 shares of Abivax worth $1.36M as of Q1 2026.
  • Progeny 3 Inc left its Abivax share count unchanged in Q1 2026.
  • Abivax made up 0.07% of Progeny 3 Inc's portfolio in Q1 2026, its #29 holding.
  • Progeny 3 Inc first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Progeny 3 Inc's Abivax position peaked at $1.65M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Progeny 3 Inc's 13F filing for Q1 2026, filed 15 May 2026.